Cajal Therapeutics is a Seattle-based biotechnology company dedicated to developing innovative medicines for serious diseases. Our team brings together deep expertise in genetics, computational biology, translational research, and drug development to advance therapies for diseases with high unmet need, including inflammatory anemias and neurodegeneration.
Company Details
- Employees
- 38
- Founded
- -
- Address
- Seattle, Wa 98109, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cajal-tx.com
- Keywords
- in genetics.
- HQ
- Seattle, WA
Cajal Therapeutics Questions
Cajal Therapeutics's website is https://cajal-tx.com
Cajal Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cajal-tx
Cajal Therapeutics has
38 employees.
View email and phone details for 38
employees at Cajal Therapeutics.
Cajal Therapeutics's industry is
Biotechnology Research
Cajal Therapeutics's top competitors are
Bonum Therapeutics,
Curi Bio,
A-Alpha Bio,
Sana Biotechnology, Inc.,
Parse Biosciences,
Variant Bio,
Shape Therapeutics Inc.,
Umoja Biopharma,
Lumen Bioscience,
Creyon Bio.
Cajal Therapeutics's categories are Biotechnology Research
Cajal Therapeutics's founding year is 2020
